Epsilon M&A Deal Report - Inverclyde Biologicals
Transaction Multiples for the Valuation of Private Companies
Source Bioscience / Inverclyde Biologicals
No EMAT :
71359
Announced Date :
30/04/2013
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Source Bioscience
Target :
Inverclyde Biologicals
Country :
England
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Founded in 1983, Inverclyde Biologicals engages in the manufacture of blood group serology reagents and diagnostic kits for blood bankers. > The manufactured products fall broadly into four...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
ns |
|
|||||
| Current |
|
|
|
|
|
|
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 07/07/2014 | IDCSalud Holding SL (Formerly Capio) | Grupo Hospitalario Quirón | Spain | * | 71222 |
| 23/02/2015 | NMC Health | EUVitro (Clinica Eugin Barcelona) | Spain | ** | 71196 |
Source: Epsilon Research / EMAT
